Cholesterol-Lowering Therapy: Evaluation of Clinical Trial Evidence

Cholesterol-Lowering Clinical Trials: A Historical Perspective
Scott M. Grundy
Scandinavian Simvastatin Survival Study (4S)
Terje R. Pedersen
The Cholesterol and Recurrent Events Trial (CARE): The Effect of Pravastatin on Coronary Events After Myocardial Infarction in Patients with Average Cholesterol Levels
Frank M. Sacks, Marc A. Pfeffer, Lemuel A. Moye, C. Morton Hawkins, Barry R. Davis, Jean L. Rouleau, Thomas G. Cole, and Eugene Braunwald
Lessons from the West of Scotland Coronary Prevention Study (WOSCOPS)
James Shepherd and Allan Gaw
Program on the Surgical Control of the Hyperlipidemias (POSCH) Trial: A Pivotal 25-Year Study
Henry Buchwald
The Air Force/Texas Atherosclerosis Prevention Study (AFCAPS/TexCAPS): Primary Prevention of Acute Major Coronary Events in Women and Men with Average Cholesterol
Stephen Weis, Michael Clearfield, Lt. Col. John R. Downs, and Antonio M. Gotto, Jr.
Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study: Clinical Implications for Cardiovascular Practice
Andrew M. Tonkin and David Hunt
Angiographic Results of Lipid-Lowering Trials: A Systematic Review and Meta-Analysis
Cheryl L. Holmes, Michael Schulzer, and G. B. John Mancini
Biochemical Correlates of Plaque Progression and Coronary Events
Melissa Ferraro-Borgida and David Waters
Lipid Therapy to Stabilize the Vulnerable Atherosclerotic Plaque: New Insights into the Prevention of Cardiovascular Events
B. Greg Brown and Xue-Qiao Zhao
Cholesterol-Lowering Trials with Carotid Ultrasonographic Outcomes
Robert P. Byington
Cholesterol Lowering Reduces Mortality: The Statins
David J. Gordon